CompaniesByCap
MGRX
Mangaceuticals Inc. (MGRX)
NASDAQ · Healthcare

Mangaceuticals Inc. Revenue 2022–2025

Mangaceuticals Inc. annual/quarterly revenue history and growth rate from 2022 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Mangaceuticals Inc. revenue for the quarter ending March 31, 2026 was 67864, a 37.91% decrease year-over-year.
  • Mangaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 429525, a 43.17% decrease year-over-year.
  • Mangaceuticals Inc. annual revenue for 2025 was 456021, a 25.96% decrease from 2024.
  • Mangaceuticals Inc. annual revenue for 2024 was 615873, a 15.81% decrease from 2023.
  • Mangaceuticals Inc. annual revenue for 2023 was 731493, a 8083.16% increase from 2022.
  • Mangaceuticals Inc. annual revenue for 2022 was 8939.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Mangaceuticals Inc. (MGRX) — Frequently Asked Questions

Mangaceuticals Inc. (MGRX) is a publicly traded US company. It has a market capitalization of $4M. In fiscal 2025 it reported revenue of $456,021 and net income of -$21M. Explore MGRX's stock price, financial statements, earnings history, margins and key ratios below.

What is Mangaceuticals Inc.'s market cap?

Mangaceuticals Inc. (MGRX) has a market capitalization of $4M.

What is the MGRX stock price?

MGRX trades at $0.36 (-0.03% on the day).

How much revenue does Mangaceuticals Inc. make?

Mangaceuticals Inc. reported revenue of $456,021 in fiscal 2025.

Is MGRX profitable?

In fiscal 2025, Mangaceuticals Inc. reported net income of -$21M.